Status:
UNKNOWN
Responsiveness of Outcome Scales in Breast Cancer Related Lymphedema
Lead Sponsor:
Marmara University
Conditions:
Lymphedema of Upper Arm
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
The aim of this study is to investigate and compare responsiveness of current lymphedema assessment scales validated in Turkish.
Detailed Description
Lymphedema is defined as the excessive and persistent accumulation of fluid, extracellular proteins, and fat in tissue spaces, caused by inefficiency of the lymphatic drainage system. It is a chronic,...
Eligibility Criteria
Inclusion
- Patients with unilateral postmastectomy lymphedema with a International Society of Lymphology-ISL) stage 2 and 3
Exclusion
- Bilateral lymphedema
- The patients who had known systemic edematogenic conditions (e.g., cardiac/hepatic/renal failure, terminal cancer, on chemotherapy), and/or with cancer recurrence
- Patients with contraindications for application of complex decongestive therapy (active cutaneous infection, deep vein thrombosis, cardiac edema, and peripheral artery disease)
Key Trial Info
Start Date :
October 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04138667
Start Date
October 19 2019
End Date
May 30 2020
Last Update
October 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University School of Medicine Department of Physical Medicine and Rehabilitation
Istanbul, Turkey (Türkiye), 34899